Shahmiri Mahdi, Cornell Bruce, Mechler Adam
La Trobe Institute for Molecular Science, La Trobe University, Melbourne VIC 3086, Australia.
SDx Tethered Membranes Pty Ltd., Sydney NSW 2029, Australia.
Biointerphases. 2017 Oct 26;12(5):05G605. doi: 10.1116/1.4995674.
Aurein 1.2 is a small cationic antimicrobial peptide, one of the shortest peptides that can exert antimicrobial activity at low micromolar concentrations. Aurein 1.2 is a surface acting peptide, following the "carpet" mechanism of thresholded membrane disruption. It is generally assumed that the activity of such cationic α-helical membrane disrupting peptides is charge driven. Here, the authors show that instead of charge interactions, aromatic phenylalanine residues of the Aurein 1.2 sequence facilitate the membrane binding. The activity of the wild type peptide was compared to mutants in which the Phe residues were substituted, singly and in tandem, with alanine. Measurements by quartz crystal microbalance, impedance spectroscopy, and dye leakage experiments demonstrated that single residue mutants retain a much-reduced activity whereas the deletion of both Phe residues prevents membrane disruption entirely. The single residue mutants exhibited an altered mechanism of action, permeabilizing but not dissolving the target membranes. These results offer a new design rule for membrane disrupting peptides with potential pharmacological applications.
奥瑞因1.2是一种阳离子抗菌小肽,是能在低微摩尔浓度下发挥抗菌活性的最短肽之一。奥瑞因1.2是一种表面作用肽,遵循阈值膜破坏的“地毯”机制。一般认为,此类阳离子α-螺旋膜破坏肽的活性是由电荷驱动的。在此,作者表明,奥瑞因1.2序列中的芳香族苯丙氨酸残基促进膜结合,而非电荷相互作用。将野生型肽的活性与苯丙氨酸残基被丙氨酸单取代和串联取代的突变体进行了比较。通过石英晶体微天平、阻抗谱和染料泄漏实验测量表明,单残基突变体的活性大幅降低,而两个苯丙氨酸残基的缺失则完全阻止了膜破坏。单残基突变体表现出改变的作用机制,使靶膜通透但不溶解。这些结果为具有潜在药理学应用的膜破坏肽提供了新的设计规则。